FDA Inspection 1340946 — CYTOVALE INC
The FDA completed an inspection of CYTOVALE INC on Oct 13, 2026 in South San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 13, 2026
- Fiscal Year
- 2027
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- South San Francisco, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 23026 | ISO 13485:2016 Clause 4.1.5 | External party controls do not include written quality agreements |
| 23258 | ISO 13485:2016 Clause 8.5.2 | Corrective action procedures not documented |
| 632 | 21 CFR 803.17(a)(2) | Lack of System for Determining MDR Events |